Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
US6057156A · kind A · utility
31Cited by
3References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1997 |
| Grant date | May 2, 2000 |
| Priority date | — |
| Expiry date | Dec 4, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enzymatic nucleic acid molecules which cleave EGFR RNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.